Registration is now open for the International Hospital Federation’s 45th World Hospital Congress, taking place on 9–11 November 2022 at the Dubai International Convention & Exhibition Centre (DWTC), UAE.
Headaches such as migraine are among the leading causes of morbidity worldwide, but most treatments provide only partial relief. While scientists know that migraine and related headaches are caused by activity in a part of the nervous system known as the trigeminal ganglion (TG), it remains unclear which genes and cell types of the TG are […]
Mayo Clinic researchers have proposed a new model for mapping the symptoms of Alzheimer’s disease to brain anatomy. This model was developed by applying machine learning to patient brain imaging data. It uses the entire function of the brain rather than specific brain regions or networks to explain the relationship between brain anatomy and mental […]
Omnicell has launched their IVX Station, an innovative solution designed to scale the benefits of leveraging IV robotic technology, making it accessible to the mainstream market.
DexCom has unveiled their new Dexcom ONE Continuous Glucose Monitoring System which will be launched in the United Kingdom in May. The Dexcom ONE system is an easy-to-use real-time CGM (rt-CGM) for people living with diabetes. Dexcom ONE is currently in review to be added to drug tariffs across the UK regions.
Nova Biomedical has launched the Nova Max Pro Creatinine/eGFR Meter System in all CE countries. Nova Max Pro is a new tool to improve kidney care through kidney function screening and early detection of kidney disease in point-of-care settings outside the hospital.
FUJIFILM Healthcare Europe previewed two new models in the ARIETTA diagnostic ultrasound range at ECR 2022 Overture, an online event that took place from March 2-6. The devices will be showcased on site at ECR 2022 in Vienna from July 13-17.
French company CardioRenal, which specializes in improving treatment at home for patients with severe chronic kidney disease, has secured €3.3 million from business angels and longstanding company shareholders as part of a round of seed capital financing.
Medical equipment made using Solvay’s Udel high-performance polysulfone (PSU) thermoplastic will be recycled at the end of their useful lives in a new sustainability initiative that the company has embarked on with Mitsubishi Chemical Advanced Materials (MCAM).
Volastra Therapeutics, an oncology company focused on exploiting chromosomal instability (CIN) as a vulnerability for cancer cells, will collaborate with Bristol Myers Squibb to discover, develop and commercialize new medicines.
April 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.